In contrast, the use of neutralizing antibodies targeting only TGF-β2 and/or β3, which can be activated by integrin-independent mechanisms, suppressed mouse BLM-induced lung fibrosis without causing systemic inflammation56. This evidence concerns the gene TGFB2 and pulmonary fibrosis.